Tobramycin
Generic Name: Tobramycin
Uses & Medical Indications
Management of cystic fibrosis patients with P. aeruginosa, superficial eye infections
Pseudomonas aeruginosa infections in CF, Bacterial conjunctivitis, Serious systemic infections
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Tobramycin works at the cellular level to correct underlying biochemical imbalances, reduce clinical symptoms, and support overall health.
Clinical Mechanism of Action (MoA)
Tobramycin exerts targeted therapeutic activity by interacting with specific cellular receptors, enzymatic pathways, or biological signaling cascades to relieve symptoms and restore physiological balance.
Dosage & Administration Guidelines
Inhalation: 300 mg twice daily. IV: 3-5 mg/kg/day in divided doses.
Inhalation: 300 mg twice daily (6 years and older)
Select dose cautiously based on renal function
Based on indication and serum levels
Dosage reduction/interval extension required for IV use
No adjustment generally needed
Side Effects & Safety Warnings
Inhalation: voice alteration, cough. Ophthalmic: tearing, irritation.
Nephrotoxicity, ototoxicity, neuromuscular blockade
Hypersensitivity to aminoglycosides
Risk of permanent hearing loss and kidney damage with systemic use
Interactions (Drugs, Food & Alcohol)
Loop diuretics, other nephrotoxic/ototoxic drugs
N/A
N/A
Pregnancy & Breastfeeding Safety
Avoid systemic use unless essential
Not recommended with systemic use
Patient Counseling & Practical Advice
Inhalation: Use a nebulizer as directed, take as close to 12 hours apart as possible.
Take as soon as remembered if at least 6 hours until next dose (for inhalation).
Auditory function, renal function, serum concentrations (for IV)
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Tobramycin was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.